Logo image of MNY

MONEYHERO LTD-A (MNY) Stock Fundamental Analysis

NASDAQ:MNY - KYG6202B1014 - Common Stock

1.84 USD
-0.03 (-1.6%)
Last: 8/29/2025, 8:00:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to MNY. MNY was compared to 70 industry peers in the Interactive Media & Services industry. The financial health of MNY is average, but there are quite some concerns on its profitability. MNY has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year MNY has reported negative net income.
MNY Yearly Net Income VS EBIT VS OCF VS FCFMNY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

The Return On Assets of MNY (-34.71%) is worse than 84.29% of its industry peers.
The Return On Equity of MNY (-59.40%) is worse than 72.86% of its industry peers.
Industry RankSector Rank
ROA -34.71%
ROE -59.4%
ROIC N/A
ROA(3y)-91.43%
ROA(5y)N/A
ROE(3y)-203.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MNY Yearly ROA, ROE, ROICMNY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 -100 -200 -300

1.3 Margins

The Gross Margin of MNY (46.12%) is worse than 68.57% of its industry peers.
In the last couple of years the Gross Margin of MNY has declined.
The Profit Margin and Operating Margin are not available for MNY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.76%
GM growth 5YN/A
MNY Yearly Profit, Operating, Gross MarginsMNY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 50 -50 -100 -150 -200

4

2. Health

2.1 Basic Checks

MNY does not have a ROIC to compare to the WACC, probably because it is not profitable.
MNY has more shares outstanding than it did 1 year ago.
The debt/assets ratio for MNY is higher compared to a year ago.
MNY Yearly Shares OutstandingMNY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
MNY Yearly Total Debt VS Total AssetsMNY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

MNY has an Altman-Z score of 2.59. This is not the best score and indicates that MNY is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.59, MNY is doing good in the industry, outperforming 64.29% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that MNY is not too dependend on debt financing.
MNY's Debt to Equity ratio of 0.01 is in line compared to the rest of the industry. MNY outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 2.59
ROIC/WACCN/A
WACC9.21%
MNY Yearly LT Debt VS Equity VS FCFMNY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 2.35 indicates that MNY has no problem at all paying its short term obligations.
MNY's Current ratio of 2.35 is in line compared to the rest of the industry. MNY outperforms 52.86% of its industry peers.
MNY has a Quick Ratio of 2.35. This indicates that MNY is financially healthy and has no problem in meeting its short term obligations.
MNY's Quick ratio of 2.35 is in line compared to the rest of the industry. MNY outperforms 54.29% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
MNY Yearly Current Assets VS Current LiabilitesMNY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 79.02% over the past year.
MNY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.64%.
The Revenue has been growing by 8.72% on average over the past years. This is quite good.
EPS 1Y (TTM)79.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)-30.64%
Revenue growth 3Y8.72%
Revenue growth 5YN/A
Sales Q2Q%-35.47%

3.2 Future

MNY is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.39% yearly.
Based on estimates for the next years, MNY will show a small growth in Revenue. The Revenue will grow by 3.31% on average per year.
EPS Next Y90.24%
EPS Next 2Y55.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.71%
Revenue Next 2Y7.76%
Revenue Next 3Y3.55%
Revenue Next 5Y3.31%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MNY Yearly Revenue VS EstimatesMNY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 20M 40M 60M 80M 100M
MNY Yearly EPS VS EstimatesMNY Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 0.1 -0.1 -0.2 -0.3 -0.4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MNY. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 10.72 indicates a reasonable valuation of MNY.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MNY indicates a somewhat cheap valuation: MNY is cheaper than 80.00% of the companies listed in the same industry.
MNY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.72.
Industry RankSector Rank
PE N/A
Fwd PE 10.72
MNY Price Earnings VS Forward Price EarningsMNY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MNY Per share dataMNY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

MNY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as MNY's earnings are expected to grow with 55.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y55.39%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MNY!.
Industry RankSector Rank
Dividend Yield N/A

MONEYHERO LTD-A

NASDAQ:MNY (8/29/2025, 8:00:01 PM)

1.84

-0.03 (-1.6%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)06-13 2025-06-13/bmo
Earnings (Next)N/A N/A
Inst Owners0.69%
Inst Owner Change-23.53%
Ins Owners9.07%
Ins Owner ChangeN/A
Market Cap79.49M
Analysts80
Price Target4.69 (154.89%)
Short Float %1.08%
Short Ratio0.35
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-300%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-11.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.72
P/S 1.11
P/FCF N/A
P/OCF N/A
P/B 1.77
P/tB 1.82
EV/EBITDA N/A
EPS(TTM)-0.97
EYN/A
EPS(NY)0.17
Fwd EY9.33%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.65
BVpS1.04
TBVpS1.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -34.71%
ROE -59.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.12%
FCFM N/A
ROA(3y)-91.43%
ROA(5y)N/A
ROE(3y)-203.56%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.76%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 2.59
F-ScoreN/A
WACC9.21%
ROIC/WACCN/A
Cap/Depr(3y)59.28%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.08%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)79.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y90.24%
EPS Next 2Y55.39%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-30.64%
Revenue growth 3Y8.72%
Revenue growth 5YN/A
Sales Q2Q%-35.47%
Revenue Next Year-2.71%
Revenue Next 2Y7.76%
Revenue Next 3Y3.55%
Revenue Next 5Y3.31%
EBIT growth 1Y20.21%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year80.34%
EBIT Next 3Y29.49%
EBIT Next 5Y21.48%
FCF growth 1Y-39.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-47.06%
OCF growth 3YN/A
OCF growth 5YN/A